Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Squamous Cell × lenvatinib × Clear all

Sponsor

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Neoplasms 8 Carcinoma, Hepatocellular 8 Thyroid Neoplasms 5 Melanoma 5 Endometrial Neoplasms 5 Carcinoma, Renal Cell 5 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Carcinoma, Non-Small-Cell Lung 4 Thyroid Cancer, Papillary 3 Colorectal Neoplasms 3 Adenocarcinoma, Follicular 3 Stomach Neoplasms 2 Ovarian Neoplasms 2 Osteosarcoma 2 Neoplasm Metastasis 2 Lymphoma 2 Glioma 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Biliary Tract Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Thyroid cancer, medullary 1 Thyroid cancer, Hurthle cell 1 Thyroid Diseases 1 Thyroid Carcinoma, Anaplastic 1 Solid Tumors 1 Sarcoma 1

Interventions

Cisplatin 24 Cetuximab 16 Radiotherapy 14 Carboplatin 13 pembrolizumab 11 Paclitaxel 9 Drug Therapy 8 Radiotherapy, Intensity-Modulated 6 Radiation 6 Fluorouracil 6 Erlotinib Hydrochloride 6 Nivolumab 5 Docetaxel 5 130-nm albumin-bound paclitaxel 5 Panitumumab 4 Chemoradiotherapy 3 Capecitabine 3 Bevacizumab 3 Albumin-Bound Paclitaxel 3 Afatinib 3 selinexor 2 figitumumab 2 Restraint, Physical 2 Radiosurgery 2 Methotrexate 2 Lapatinib 2 Everolimus 2 Esophagectomy 2 Cyclophosphamide 2 zalutumumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡